From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest News

RDT
premium content

One less AIM CEO with a career in porn - Charles Clark "reshuffles himself" at Rosslyn Data

AIM Dog with fleas Rosslyn Data (RDT) has announced a wholesale reshuffle of its boardroom which saddens me greatly as it now means that there is one less AIM CEO who had a career in porn. Farewell Charles Clark for you will be missed.

CIR
premium content

Circassia shares crash on cat trial failure - the latest Neil Woodford Biotech disaster

Hats off to veteran journalist Tim Blackstone who called Circassia (CIR) as a short with a £900 million market cap on January 16 this year HERE. Today the shares have crashed by 64% to 98.5p giving it a market cap of just £261 million. Tim Blackstone dared to go up against Neil Woodford with this call as he is the largest shareholder. It looks like another biotech disaster for Woodie. 

Pinocchio
premium content

Video: Is Dodgy Dave Cameron simply the most dishonest PM in history

Slippery Dodgy Dave just wont answer the questions. Is he the most dishonest PM in history. As you vote on Thursday ask yourself if you believe a word that this man says. If your answer is no, as mine was, you must vote for Brexit. The video shows classic Dodgy Dave from the weekend.

CUBA
premium content

Running out of cash Leni Gas Cuba accelerates the spunk with another crap deal

As Cynical Bear showed HERE, Leni Gas Cuba (CUBA) is running out of cash fast. Given its monstrous record of lying to investors, buying worthless assets from its main players without telling anyone and of spunking cash only a total fool will back the looming and inevitable placing. So what to do? Aha, piss more away on another crap deal. And so..

Amanda-Van-Dyke
premium content

No Major Pullbacks In Sight for Gold Stocks Until 2017

Oh Goodie Goodie I hope Amanda van Dyke's colleague Jordan Roy Byrne is correct as we own a stack of gold shares. He argues that: Gold performed well last week but there is resistance at the $1300 mark. There are many factors in play causing volatility in the gold price but this has not effected the stocks which have performed well without any significant corrections.

BOX
premium content

Boxhill Technologies – Do birds of a feather stick together?

Following on from Tom’s explosive piece over the weekend referencing this letter relating to the Mediacorp / Purple Lounge debacle and the dodgy characters involved, I couldn’t help but pick up on the Boxhill Technologies (BOX) connection as I continue to be amazed that Lord Razzall hangs out with some of these characters.

Malcolm-On-Motorcycle
premium content

Investments that Shouldn't Be Affected by Brexit - and They're Not Shares.

Hello Share Smashers. The big vote is only a gnat's bite away now. I'm still undecided. Perhaps I won't bother, as my dear old dad used to say that no election was ever decided by one vote, anyway. But any road up, it is not wise to either buy or sell shares at the moment, in my view. Not unless there is a pressing individual reason why a stock should be acquired ot dumped.

EU_flag
premium content

Video the EU tried to stop being filmed as £2 billion waste exposed

I think the video below is fairly self-explanatory. Would you not rather your money was spent elsewhere?

Bearcast
premium content

Tom Winnifrith Bearcast: Cancer, Fewer Bearcasts & Articles & Advanced Oncotherapy

I start with a few personal issues and then in this bearcast I explain why the mountain list of red flags at cancer play Advanced Oncotherapy (AVO) matter but what will be the killer blow and when I shall deliver it.

NXR

Norcros strong results - buy

Supplier of branded showers, taps, bathroom accessories, tiles and adhesives, Norcros (NXR) has announced results for its year ended 31st March 2016 and that “with our leading market positions, portfolio of strong brands, continued new product investment and self-help initiatives focused on market share gain, the board remains confident that the group should continue to make further progress for the year ending 31 March 2017”.

HNR
premium content

The very Simple question Highlands Natural Resources is Refusing to answer

Highlands Natural Resources (HNR) is a dog with fleas which screams "over-ramped crap" at every level. Our coverage here is a comprehensive demonstration of why the shares are a sell at almost every level. It almost seems poor form to kick a man who is down. However...

VAST
premium content

Vast Resources: Shareholder activism at its best – make sure you get involved NOW

Despite Vast Resources’ (VAST) share price taking a bit of a beating last week, it is great to see its private investors getting together to try to make a difference, rather than just sitting back and accepting their fate.  As a big fan of shareholder activism, I’m more than happy to do my bit to publicise the cause and try to get more people involved.

SCLP
premium content

Scancell – drug supply problems and a bet with the Sheriff

AIM-listed cancer-buster Scancell (SCLP) announced on Friday that its seven-year-old supply of SCIB-1 vaccine trial doses has had to be withdrawn as the product is no longer within the original specification: it has degraded. The formal trial ended last year, but eight patients elected to continue the treatment which has had to come to an abrupt halt until a new batch is manufactured (about 9-12 months). Bad news, but perhaps not as bad as it might seem.

Newsboy

Notes from Underground: Show Me the Money!

Two hard days in the pizza business gave me a roaring headache on Friday, so I crossed Clerkenwell Road to the Sainsbury's for some pain reliever.

PMO
premium content

Premier Oil - Holed Below the Waterline? (Part 2)

Yesterday in Part 1, I outlined the gravity of the situation facing Premier Oil’s (PMO) equity investors. In that piece, I presented my view that the purchase of E.ON’s North Sea assets was an attempt to temporarily fix a covenant breach situation, but that any profits it generates are unlikely to be material against Premier’s debt pile.

AVO
premium content

Advanced Oncotherapy Red Flag Season part 3 - Tell us about Sinophi?

On 25 March 2015 Advanced Oncotherapy (AVO) announced what it claimed was a major breakthrough in China, what it termed the "first major sale of a LIGHT system" in China. Well that was the headline. The customer was a firm called Sinophi. The shares zoomed on this $40 million order. Jolly good news. 37 days later the company raised £20 million in a placing at 8p. But did anyone care to look underneath the PR spin? No. Lets start with Sinophi Healthcare Limited.

PMO
premium content

Premier Oil - Holed Below the Waterline? (Part 1)

Anyone lucky enough to buy independent exploration and production company Premier Oil (PMO) around the January lows achieved a two-bagger in quick time as the shares rallied rapidly from around 20p to achieve a high of 75p last month. It is currently capitalised at £360 million ($500 million) and is a favourite on the bulletin boards. Sadly, it’s not yet clear that Premier has its house in order. There could be some serious pain yet to come.

Bearcast
premium content

Tom Winnifrith Bearcast: Brexit Bollocks from Gary Newman and the stench from Strat Aero & Regent Pacific (i.e Plethora)

I start with a discussion on how the sad events in Yorkshire may sway the Brexit vote before turning to Gary Newman's nonsense earlier today about Brexit, house prices and Foxtons (FOXT). Then it is onto a detailed look at Strat Aero (AERO) and also Regent Pacific, the new owner of Plethora (PLE) and in both cases its red flags ahoy big time.

Amanda-Van-Dyke
premium content

A Sinner Repenteth: Ex Greenpeace boss Patrick Moore puts the case for nuclear power & GM crops

It's not our own mad star gazing Patrick Moore who, apart from anything else, died four years ago, but the ex boss of Greenpeace who has seen the light. Praise the Lord! In this week's podcast with the colleagues of Amanda Van Dyke at Palisade Capital, a sinner repenteth. 

LRM
premium content

Lombard Risk Management - Questions Mount for kiss of Death Phil "InterX" Crawford

Phil "InterX" Crawford is still to answer the question of the circumstances of his departure from Oracle. Meanwhile there are increasing questions about yesterday's £8 million rescue bailout, in addition to the ones posed HERE. Lets start with that profits warning on 19 April.

Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

Most Read in the Past Seven Days

That Was the Week that Was

 

CTAI

Catenai – monster dilution

Time left: 13:50:39